Loading chat...
OH HB51
Bill
Status
Introduced
2/26/2009
Primary Sponsor
Barbara Boyd
Click for details
AI Summary
- Enacts section 3701.265 of the Revised Code to establish the Triple Negative Breast Cancer Commission in Ohio
- Defines triple negative breast cancer as the subtype lacking receptors for estrogen, progesterone, and HER2 protein, making it resistant to targeted drugs like tamoxifen and trastuzumab
- Commission purposes include understanding why triple negative breast cancer disproportionately affects African-American women, Hispanic women, women under 40, and those in lower socioeconomic conditions; promoting research and study by scientists and physicians; and increasing public awareness
- Director of Health appoints commission members, including healthcare professionals and individuals personally affected by the disease, with members serving without compensation unless serving as part of regular employment duties
- Commission shall annually elect a chairperson and meet at least twice per year, with a majority of members constituting a quorum for conducting business
Legislative Description
To create the Triple Negative Breast Cancer Commission.
Triple Negative Breast Cancer Commission
Last Action
To Health
2/26/2009
Full Bill Text
No bill text available